Immuno-Oncology

In this product category, you will find reports and other services providing you with the most uptodate business and competitive intelligence information on immuno-oncology including immune checkpoint inhibitors and activators, and modulators of the tumor-microenvironment. The range of products covers industry data as well as in-depth strategic assessment and analysis of immuno-oncology companies, technologies, targets, R&D pipeline as well as market and sales information.

Subscribe to
our newsletters!

Showing all 5 results

  • June of 2019
    Package of two reports with in depth analysis of T-cell and NK cell engaging bispecific antibodies and competitor analysis of 271 unique bispecific antibody-based constructs
     3150.00  2520.00
  • July of 2019
    This Target Pipeline List provides an overview of selective and bispecific CD137 receptor agonists in development for treatment of solid tumors.
     150.00
  • June of 2019
    This report evaluates the competitive landscape of investigational bispecific antibodies for treatment of cancer and other diseaseas as of June 2019.
     800.00
  • January of 2019
    This Target Pipeline List provides a pipeline overview of EP4 receptor antagonists in development for treatment of cancer
     50.00
  • December of 2018
    Information about R&D projects is identified and retrieved from company publications including, but not limited to, press releases, presentations, website disclosures, SEC publications, regulatory documents, scientific abstracts and full papers,...
     1500.00  1350.00